Eric Esser's most recent trade in Telesis Bio Inc was a trade of 200,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 17, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Telesis Bio Inc | Eric Esser | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
Telesis Bio Inc | Eric Esser | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 100,000 | 129,260 | - | 0 | Common Stock | |
Telesis Bio Inc | Eric Esser | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 263,600 | 263,600 | - | - | Stock Option (right to buy) | |
Telesis Bio Inc | Eric Esser | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 32,600 | 32,600 | - | 0 | Common Stock | |
Telesis Bio Inc | Eric Esser | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.53 per share. | 22 Jun 2023 | 3,340 | 29,260 | - | 0.5 | 1,764 | Common Stock |